Ilika Technologies is focused on high throughput methods of screening, synthesising and characterising very large numbers of new materials.
High throughput combinatorial chemistry has already had a significant impact on the pharmaceutical industry where the technique is widely used within the drug discovery process to synthesise and screen large numbers of new compounds. Ilika has been formed to introduce similar techniques to other chemical and materials industries, with the objective of dramatically accelerating the discovery of new materials with commercial value.
|
As at 31 Dec 2012 |
IP Group holding |
IP Venture Fund* holding |
8.8% |
7.6% |
| |
*IP Group has a 10%
economic interest in IP
Venture Fund |
Holdings represent undiluted beneficial equity interest excluding debt